Mifamurtide in metastatic and recurrent osteosarcoma: a patient access study with pharmacokinetic, pharmacodynamic, and safety assessments. [electronic resource]
Producer: 20140225Description: 238-44 p. digitalISSN:- 1545-5017
- Acetylmuramyl-Alanyl-Isoglutamine -- administration & dosage
- Adolescent
- Adult
- Bone Neoplasms -- drug therapy
- Child
- Child, Preschool
- Drug-Related Side Effects and Adverse Reactions
- Female
- Follow-Up Studies
- Humans
- Immunologic Factors -- administration & dosage
- Male
- Middle Aged
- Neoplasm Grading
- Neoplasm Metastasis
- Neoplasm Recurrence, Local -- drug therapy
- Osteosarcoma -- drug therapy
- Phosphatidylethanolamines -- administration & dosage
- Prognosis
- Safety
- Survival Rate
- Tissue Distribution
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.